Vericel Corp (NAS:VCEL)
$ 51.53 0.4 (0.78%) Market Cap: 2.50 Bil Enterprise Value: 2.49 Bil PE Ratio: 9,999.00 PB Ratio: 10.68 GF Score: 79/100

Vericel Corp at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 04:15PM GMT
Release Date Price: $16.83 (+4.40%)
Jonathan Guskind
Morgan Stanley - Executive Director, Healthcare Investment Banking

Good afternoon, everyone. My name is Jonathan Guskind from Morgan Stanley's Healthcare Investment Banking team. It's my pleasure today to have with us from Vericel, Nick Colangelo, the Chief Executive Officer.

Before we get started, just a quick note. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures or at the registration desk.

Nick, thanks again for joining us at the conference. To get started, why don't we start with a brief overview of Vericel and its evolution over the past few years?

Dominick C. Colangelo
Vericel Corporation - CEO, President & Director

Yes. Well, great, John. Thanks for having us here. We're really excited. And before I begin, I'll just say that our discussion will contain some forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot